Airway Management and Sedation

16 Airway Management and Sedation


David C. Kramer, Irene Osborn, and Meagen Gaddis


When evaluating a neurocritical care patient for intubation, the following considerations must be assessed: (1) urgency of airway management, (2) assessment of ability to secure the airway, (3) issues related to “full stomach” and aspiration risk, (4) intracranial pressure, (5) hemodynamics, and (6) immobilization and restraints as impediments to securing the airway. The basic pharmacokinetics and clinical application of commonly used drugs to facilitate induction, intubation, and sedation will be reviewed.



Case Example


A 64-year-old male presents with confusion, lethargy, and new left hemiparesis. His blood pressure is 180/105 mm Hg, and his heart rate is 43. His head computed tomography (CT) scan shows a large right-sided intracerebral hemorrhage with edema and a midline shift. The patient had previously undergone a tracheostomy at age 33 after a motor vehicle accident.


Questions



  • Is the patient protecting his airway?
  • What is the O2 saturation and arterial blood gas (ABG)?
  • Has the patient received any sedation?
  • Has the patient received any treatment for elevated intracranial pressure (ICP)?

Urgent Orders



History and Examination


History


Determine the mechanism of injury and whether there is any associated trauma (craniofacial, thoracic, or pulmonary) or spinal cord injury. If there is a plan for surgery, the patient may need to be intubated for general anesthesia. Assess for previous history of a difficult airway, including a history of prolonged intubation, head or neck radiation or surgery, history of rheumatoid arthritis (associated with atlantoaxial subluxation), Down’s syndrome (associated with abnormal airway anatomy and atlantoaxial subluxation), ankylosing spondylitis (which may limit neck movement), or a history of tracheostomy. A cardiac and pulmonary history should be assessed as well as a history of smoking. A history of last ingestion should be undertaken to ascertain aspiration risk.


Physical Examination


It is critical to assess for difficulty in securing an airway, which can occur in roughly 10% of intensive care unit (ICU) patients (see H-LEMOON below). Neuro-ICU (NICU) patients have additional risks related to elevated ICP, craniofacial trauma, or cervical spine immobilization.


Neurologic Examination



  • A full neurologic examination, including assessment of mental status, cranial nerves, motor skills, and reflexes, as well as a sensory and cerebellar exam, should be performed on all patients, once the patient is stabilized.
  • Particular attention should be given to mental status and the ability of the patient to protect his or her airway. Patients with neuromuscular weakness or fatigable weakness should be assessed according to parameters described in Chapters 11 and 12.

Differential Diagnosis



  • Indications for intubation include failure to protect the airway, failure to maintain the airway, failure of oxygenation, failure of ventilation, anticipated clinical deterioration (neurologic worsening, expanding neck mass, etc.), and the need for general anesthesia (planned surgery, status epilepticus management, etc.).
  • Contraindications to intubation include total loss of facial landmarks, total airway obstruction, and an anticipated difficult airway (relative contraindication).

Life-Threatening Diagnoses Not to Miss



  • Airway obstruction requiring emergency tracheostomy
  • Unstable C-spine requiring precautions during intubation
  • Craniofacial trauma or surgery that places patients at risk for pneumocephalus with bag mask ventilation

Diagnostic Evaluation



  1. Assess difficulty of airway. The pneumonic H-LEMOON can be applied (Table 16.1). In patients in whom the difficult airway may be anticipated, alternative airway devices such as the Rusch FlexiSlip (Teleflex Medical, Research Triangle Park, NC) stylet, the gum elastic bougie, the fiberoptic scope, video laryngoscopes, or an intubating laryngeal mask airway (ILMA) may prove helpful. A laryngeal mask airway (LMA) of the appropriate size should be readily available for the patient in whom intubation is anticipated to be difficult.


































    Table 16.1 The H-LEMOON Pneumonic

    Less Difficult Airway More Difficult
    History No history of difficult intubation History of difficult intubation or tracheostomy
    Look externally Normal face and neck
    No facial or cervical pathology
    Abnormal facial shape
    Facial hair
    Overhanging incisors
    Narrow mouth
    Inability to protrude mandible
    Micrognathia
    Poor temporomandibular joint mobility
    Long, high-arched palate
    Facial or cervical pathology
    Short, thick neck
    Tracheal deviation
    Presence of vomitus or blood in oropharynx
    Evaluate the 3-3-2 rule Mouth opening >3 finger breadths (4 cm)
    Hyoid-chin distance >3 finger breadths (4 cm)
    Thyroid cartilage-mouth of floor <2 finger breadths
    Mouth opening <3 finger breadths (4 cm)
    Hyoid-chin distance <3 finger breadths (4 cm)
    Thyroid cartilage-mouth of floor >2 finger breadths
    Mallampati classification (best performed with the patient sitting, tongue protruding, and not phonating) Class I: Fully visible tonsils, uvula, and soft palate
    Class II: Visibility of hard and soft palate and upper portion of the tonsils and uvula
    Class III: Soft and hard palate and base of uvula are visible
    Class IV: Only hard palate visible
    Obstruction and Obesity No airway obstruction
    BMI <30 kg/m2 and/or neck circumference <60 cm
    Pathology in or surrounding the upper airway, difficulty swallowing secretions, stridor (ominous and occurs when <10% of airway patent), muffled (hot-potato) voice
    BMI >30 kg/m2 and/or neck circumference >60 cm
    Neck mobility Complete flexion and extension of neck Limited ROM of neck
    Presence of halo or neck immobilization devices
    History of cervical instrumentation

    Abbreviations: BMI, body mass index; ROM, range of motion.


  2. Assess aspiration risk. Pneumonia secondary to aspiration and microaspiration is a common source of infection following intubation. Neurocritically ill patients have potential for aspiration secondary to decreased or altered level of consciousness, decreased gastric motility, increased sympathetic tone, and intermittent feeds. The goal of aspiration preventive measures is to decrease gastric stomach content volume, raise the pH of stomach content to greater than 7.25, and decrease the time of induction of unconsciousness to intubation.

    The American Society of Anesthesiology has suggested a period of 2 hours after the ingestion of clear liquids, 6 hours after a “light meal,” and 8 hours after a meal of fried or fatty food be utilized as a guideline for surgical patients undergoing elective surgical procedures.1 The administration of 100% oxygen to preoxygenate the patient, avoidance of positive-pressure ventilation during induction, the use of rapid sequence induction (RSI), and the institution of cricoid pressure have been advocated to decrease the risk of aspiration.


  3. Assess ICP. It is essential for the laryngoscopist to take maneuvers to minimize elevations of ICP, such as to minimize laryngeal stimulation and to use maneuvers to avoid bucking, movement, and vomiting. Lidocaine 1% 1.0 mg/kg IV suppresses the cough reflex, may lower cerebral oxygen demand, reduces bronchospasm, and should be used in patients with suspected elevated ICP.
  4. Assess hemodynamics. Intubation in the intensive care unit is often complicated by hemodynamic compromise and cardiovascular collapse. As many as a quarter of ICU patients may experience hemodynamic collapse, 10% experience cardiac arrhythmias, and 2% have cardiac arrest coincident with endotracheal intubation. Should multiple attempts at intubation be required, the incidence of cardiac arrest increases 1600%.1

    In the hypovolemic patient who is hypotensive, a bolus of intravenous (IV) fluid is indicated. The judicious use of vasopressor agents may be indicated should hypotension persist. The use of etomidate as an induction agent should be considered in patients who are elderly, critically ill, or have tenuous hemodynamics. Etomidate (even a single dose) can suppress steroidogenesis and cause delayed hypotension after intubation related to relative adrenal insufficiency.


  5. Assess immobilizations and restraints. Neurocritical care patients may sometimes be immobilized to prevent movement, which could be detrimental or dangerous to their condition. Devices such as hard cervical collars and halo frames restrict neck mobility. In patients with C-spine precautions who require emergent intubation, a two-person intubation can be undertaken, with one person providing in-line mobilization once the anterior portion of the cervical collar is removed. In the nonemergent setting, fiberoptic bronchoscopy should be strongly considered.

    The halo device provides the most rigid form of external cervical immobilization and prevents proper positioning for laryngoscopy by restricting atlanto-occipital extension. Oral intubation is often possible, but it is a function of other variables, such as mouth opening, tongue size, upper dentition, and ability to prognath the lower jaw forward. Techniques include awake or sedated fiberoptic intubation and the ILMA performed awake or asleep. Video laryngoscopy may be successful, but it requires expertise, and mask ventilation is often possible with the addition of oral airways. It is imperative that clinicians involved have: (1) skills and equipment for alternative intubation techniques, (2) a neurosurgeon or professional who can safely remove the halo if necessary, and (3) a rescue plan in case of failed ventilation in these challenging patients.


Treatment


Intubation



  1. Equipment and preparation. The most commonly used laryngoscope is a Mac #3 curved blade, and in circumstances of larger patients, a Mac #4. A Miller #3 or #4 (straight blade) can also be used. A Mac blade is placed in the vallecula, while a Miller blade is placed over the epiglottis and lifted. Video-assisted laryngoscopes are gaining popularity and allow for group visualization of the airway. Such devices include the Glidescope (Saturn Biomedical System Inc., Burnaby, BC, Canada), the McGrath (Aircraft Medical, Edinburgh, Scotland), Airtraq (Prodol, Meditec S.A., Vizcaya, Spain), and the AWS (Pentax Corp., Montvale, NJ) (Table 16.2).




















    Table 16.2 Equipment Checklist
    Endotracheal tube with a stylet (usually 8.0 in men and 7.0 in women)
    Ambu bag with PEEP device attached to 100% O2
    Suction
    10 mL syringe
    Intubating laryngeal mask airway
    Capnometer/CO2 detector
    Oral and nasal airway
    Tape and tincture of benzoin

    Abbreviation: PEEP, positive end expiratory pressure.


    As part of the preparation for intubation, the cuff of the endotracheal tube (ETT) should be checked and lubricated, the light source on the laryngoscope should be confirmed, contraindications to medications should be reviewed, free-flowing IV access should be present, and blood pressure (BP), O2, and heart rate (HR) continuous monitoring should be applied. In case of hypotension related to induction, the laryngoscopist should have available phenylephrine (mix 10 mg in 250 mL of normal saline (NS), 40 µg/mL; never inject phenylephrine directly from vial without dilution). In patients who are bradycardic and hypotensive, ephedrine is preferred (50 mg in 10 mL; 5 mg/mL).


  2. Positioning. Place the patient in sniffing position (neck flexion and head extension) or neck extension to obtain adequate visualization of the glottic opening. Avoid this in patients with known or suspected C-spine injury.
  3. Pretreatment. Preoxygenate with 100% O2 for at least 1 minute prior to attempted intubation, and ensure that the O2 saturation is at least 95% prior to an attempt. Lidocaine 1% 1.0 mg/kg IV suppresses the cough reflex, may lower cerebral oxygen demand, and reduces bronchospasm. Lidocaine spray can rarely cause methemoglobinemia, but it can be used to blunt coughing and gagging. IV lidocaine should be used in any patient with intracranial pathology, as it may blunt increases in ICP.
  4. Induction (Table 16.3)2
    image

    Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

Aug 30, 2016 | Posted by in NEUROSURGERY | Comments Off on Airway Management and Sedation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access